Physician profile
Peter S Johnston
NPI 1194946095
$705,793.13
in general payments reported to CMS, 2019-2025
16 companies · $261K in 2025
The $261K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $15K · 2021: $27K · 2022: $39K · 2023: $112K · 2024: $217K · 2025: $261K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $286K · Royalty Or License: $283K · Travel and Lodging: $16K · Food and Beverage: $4,441 · Gift: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $285,781.25 |
| Royalty Or License | $282,822.56 |
| Travel and Lodging | $15,927.48 |
| Food and Beverage | $4,440.55 |
| Gift | $725.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $659,379.94 | 2019-2025 | Inset System |
| Wright Medical Technology, INC. | $24,328.51 | 2019-2020 | |
| Stryker Corporation | $19,526.61 | 2019-2025 | Blueprint Patient Specific Instrumentation, Axsos, Aequalis Reversed II |
| Advanced Orthopaedic Solutions, INC. | $1,911.33 | 2019 | |
| Zimmer Biomet Holdings, INC. | $190.01 | 2019-2024 | |
| Smith+Nephew, INC. | $156.31 | 2022-2023 | Journey II, Mini-Open Latarjet |
| Horizon Therapeutics Plc | $74.86 | 2019-2021 | |
| Medical Device Business Services, INC. | $50.33 | 2019 | |
| Embody, INC. | $47.93 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $26.67 | 2025 | Exparel |
| Ferring Pharmaceuticals INC. | $18.91 | 2020 | |
| Catalyst Orthoscience | $18.00 | 2019 | |
| Medartis INC. | $17.98 | 2021 | |
| Fx Shoulder Solutions, INC | $15.70 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.48 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.56 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$68,300.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.